Back to SC SCS Capital Management LLC

ANRO

6 quarters

Position history for SCSCS Capital Management LLC's holdings in Alto Neuroscience, Inc.

Yes. SCS Capital Management holds 16,840 shares of ANRO (Alto Neuroscience), worth $444,408, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. SCS Capital Management has held ANRO since Q1 2025, across 6 quarterly 13F filings.

Current Value

$444,408

Current Shares

16,840

Total Value Change

+$300,170

Total Shares Change

-49,937

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
16,840
0.0%
$444,4080.0%$26.39
0
2026-Q1
Decreased
16,840
-49.6%
$378,5630.0%$22.48
0
2025-Q4
Decreased
33,389
-50.0%
$594,3240.0%$17.80
0
2025-Q3
Unchanged
66,777
0.0%
$268,4440.0%$4.02
0
2025-Q2
Unchanged
66,777
0.0%
$146,9090.0%$2.20
0
2025-Q1
New
66,777
-
$144,2380.0%$2.16
31

Other major holders of ANRO: BlackRock, Inc., Adage Capital Partners GP, L.L.C., Vanguard Capital Management LLC, FMR LLC, Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used